AKRO
Price
$29.32
Change
+$0.92 (+3.24%)
Updated
Dec 20, 04:59 PM (EDT)
80 days until earnings call
MDWD
Price
$16.54
Change
+$0.05 (+0.30%)
Updated
Dec 23, 11:17 AM (EDT)
80 days until earnings call
Ad is loading...

AKRO vs MDWD

Header iconAKRO vs MDWD Comparison
Open Charts AKRO vs MDWDBanner chart's image
Akero Therapeutics
Price$29.32
Change+$0.92 (+3.24%)
Volume$28.32K
CapitalizationN/A
MediWound
Price$16.54
Change+$0.05 (+0.30%)
Volume$100
CapitalizationN/A
AKRO vs MDWD Comparison Chart
Loading...
AKRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDWD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AKRO vs. MDWD commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKRO is a Hold and MDWD is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (AKRO: $29.34 vs. MDWD: $16.49)
Brand notoriety: AKRO and MDWD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AKRO: 253% vs. MDWD: 217%
Market capitalization -- AKRO: $2.05B vs. MDWD: $177.6M
AKRO [@Biotechnology] is valued at $2.05B. MDWD’s [@Biotechnology] market capitalization is $177.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKRO’s FA Score shows that 0 FA rating(s) are green whileMDWD’s FA Score has 1 green FA rating(s).

  • AKRO’s FA Score: 0 green, 5 red.
  • MDWD’s FA Score: 1 green, 4 red.
According to our system of comparison, MDWD is a better buy in the long-term than AKRO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKRO’s TA Score shows that 4 TA indicator(s) are bullish while MDWD’s TA Score has 3 bullish TA indicator(s).

  • AKRO’s TA Score: 4 bullish, 4 bearish.
  • MDWD’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, AKRO is a better buy in the short-term than MDWD.

Price Growth

AKRO (@Biotechnology) experienced а +1.56% price change this week, while MDWD (@Biotechnology) price change was -4.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

AKRO is expected to report earnings on Mar 13, 2025.

MDWD is expected to report earnings on Mar 13, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AKRO($2.05B) has a higher market cap than MDWD($178M). MDWD YTD gains are higher at: 62.144 vs. AKRO (25.653). MDWD has higher annual earnings (EBITDA): -6.58M vs. AKRO (-232.85M). AKRO has more cash in the bank: 717M vs. MDWD (45.6M). MDWD has less debt than AKRO: MDWD (6.46M) vs AKRO (36.4M). MDWD has higher revenues than AKRO: MDWD (19.7M) vs AKRO (0).
AKROMDWDAKRO / MDWD
Capitalization2.05B178M1,151%
EBITDA-232.85M-6.58M3,541%
Gain YTD25.65362.14441%
P/E RatioN/AN/A-
Revenue019.7M-
Total Cash717M45.6M1,572%
Total Debt36.4M6.46M563%
FUNDAMENTALS RATINGS
MDWD: Fundamental Ratings
MDWD
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
4
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AKROMDWD
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
89%
Momentum
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
82%
MACD
ODDS (%)
N/A
Bearish Trend 4 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 4 days ago
77%
Advances
ODDS (%)
Bullish Trend 7 days ago
84%
Bullish Trend 13 days ago
77%
Declines
ODDS (%)
Bearish Trend 5 days ago
83%
N/A
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 7 days ago
82%
N/A
View a ticker or compare two or three
Ad is loading...
AKRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDWD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GLESX13.350.25
+1.91%
GS Energy Infrastructure Fd R6 Shares
EIVFX12.860.13
+1.06%
Allspring Special Large Cap Value R6
DFVEX27.420.27
+0.99%
DFA US Vector Equity I
CAMYX26.180.10
+0.38%
Cambiar International Equity Instl
EEMGX7.910.01
+0.13%
MFS Emerging Markets Equity Research R4

AKRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, AKRO has been loosely correlated with ETNB. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if AKRO jumps, then ETNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKRO
1D Price
Change %
AKRO100%
+3.31%
ETNB - AKRO
63%
Loosely correlated
+12.94%
DNLI - AKRO
44%
Loosely correlated
-0.19%
BEAM - AKRO
44%
Loosely correlated
+8.04%
PLRX - AKRO
43%
Loosely correlated
-0.68%
CRSP - AKRO
43%
Loosely correlated
+0.83%
More

MDWD and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDWD has been loosely correlated with PHIO. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if MDWD jumps, then PHIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDWD
1D Price
Change %
MDWD100%
-4.13%
PHIO - MDWD
35%
Loosely correlated
+1.15%
AKRO - MDWD
33%
Poorly correlated
+3.31%
KANT - MDWD
30%
Poorly correlated
-1.83%
KALA - MDWD
26%
Poorly correlated
-1.33%
SYBX - MDWD
26%
Poorly correlated
+3.52%
More